HALOPERIDOL

HALOPERIDOL was reported 24939 times

These side effects are most commonly reported by patients taking HALOPERIDOL:

# Side effect Count
0 DRUG INEFFECTIVE 2184
1 DRUG INTERACTION 1709
2 NEUROLEPTIC MALIGNANT SYNDROME 1646
3 OFF LABEL USE 1426
4 EXTRAPYRAMIDAL DISORDER 1253
5 WEIGHT INCREASED 1227
6 TOXICITY TO VARIOUS AGENTS 1049
7 AGITATION 881
8 SOMNOLENCE 825
9 CONDITION AGGRAVATED 821
10 PYREXIA 817
11 DELIRIUM 779
12 CONFUSIONAL STATE 753
13 VOMITING 727
14 DEATH 725
15 TREMOR 700
16 NAUSEA 674
17 ELECTROCARDIOGRAM QT PROLONGED 672
18 SEDATION 649
19 PSYCHOTIC DISORDER 640
20 DYSTONIA 637
21 TACHYCARDIA 633
22 AKATHISIA 632
23 AGGRESSION 586
24 SUICIDE ATTEMPT 579
25 PNEUMONIA 577
26 HYPOTENSION 575
27 DIARRHOEA 566
28 ANXIETY 562
29 NEUTROPENIA 549
30 DYSPNOEA 545
31 FATIGUE 537
32 FALL 534
33 SCHIZOPHRENIA 525
34 PRODUCT USE IN UNAPPROVED INDICATION 517
35 OVERDOSE 509
36 ACUTE KIDNEY INJURY 498
37 INSOMNIA 471
38 COMPLETED SUICIDE 456
39 HALLUCINATION 451
40 HYPERTENSION 450
41 TREATMENT NONCOMPLIANCE 448
42 MALAISE 443
43 CATATONIA 442
44 RHABDOMYOLYSIS 440
45 CARDIAC ARREST 437
46 CONSTIPATION 437
47 LEUKOPENIA 434
48 HALLUCINATION, AUDITORY 430
49 BLOOD CREATINE PHOSPHOKINASE INCREASED 421
50 MUSCLE RIGIDITY 413
51 PARKINSONISM 407
52 HYPONATRAEMIA 405
53 DELUSION 396
54 DEPRESSED LEVEL OF CONSCIOUSNESS 384
55 SUICIDAL IDEATION 384
56 TARDIVE DYSKINESIA 380
57 RESPIRATORY FAILURE 378
58 RESTLESSNESS 370
59 DEPRESSION 369
60 PULMONARY EMBOLISM 359
61 DYSPHAGIA 357
62 DIZZINESS 356
63 ASTHENIA 352
64 DYSKINESIA 352
65 SEIZURE 350
66 HYPERHIDROSIS 337
67 LOSS OF CONSCIOUSNESS 334
68 SALIVARY HYPERSECRETION 334
69 GENERAL PHYSICAL HEALTH DETERIORATION 318
70 BRADYCARDIA 314
71 ABDOMINAL PAIN 307
72 SEROTONIN SYNDROME 306
73 COMA 303
74 RENAL FAILURE 303
75 DRUG ABUSE 299
76 SEPSIS 299
77 HEADACHE 297
78 INTENTIONAL OVERDOSE 297
79 PAIN 296
80 COGNITIVE DISORDER 290
81 PNEUMONIA ASPIRATION 290
82 THROMBOCYTOPENIA 289
83 GAIT DISTURBANCE 288
84 WEIGHT DECREASED 286
85 ABNORMAL BEHAVIOUR 277
86 DYSARTHRIA 277
87 DECREASED APPETITE 270
88 WHITE BLOOD CELL COUNT DECREASED 257
89 HYPERPROLACTINAEMIA 255
90 DISORIENTATION 254
91 MENTAL IMPAIRMENT 251
92 ANAEMIA 249
93 CARDIO-RESPIRATORY ARREST 247
94 PSYCHOMOTOR HYPERACTIVITY 246
95 DIABETES MELLITUS 243
96 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 243
97 LETHARGY 242
98 URINARY TRACT INFECTION 236
99 WHITE BLOOD CELL COUNT INCREASED 235
100 MUSCULOSKELETAL STIFFNESS 232
101 MENTAL STATUS CHANGES 231
102 IRRITABILITY 228
103 URINARY RETENTION 225
104 HYPOTHERMIA 219
105 PLATELET COUNT DECREASED 219
106 SPEECH DISORDER 219
107 DEHYDRATION 217
108 MANIA 213
109 ALTERED STATE OF CONSCIOUSNESS 211
110 OBSESSIVE-COMPULSIVE DISORDER 202
111 DRUG HYPERSENSITIVITY 198
112 INCREASED APPETITE 198
113 BLOOD CREATININE INCREASED 196
114 HOSPITALISATION 196
115 MYOCARDITIS 196
116 RASH 195
117 CHEST PAIN 194
118 ENCEPHALOPATHY 194
119 UNRESPONSIVE TO STIMULI 194
120 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 193
121 TORSADE DE POINTES 193
122 OEDEMA PERIPHERAL 191
123 LEUKOCYTOSIS 188
124 THERAPY NON-RESPONDER 187
125 MYOCLONUS 183
126 PRURITUS 183
127 TREATMENT FAILURE 183
128 MENTAL DISORDER 182
129 ALANINE AMINOTRANSFERASE INCREASED 181
130 DISTURBANCE IN ATTENTION 180
131 HYPOXIA 180
132 RENAL IMPAIRMENT 180
133 EUPHORIC MOOD 178
134 NEUTROPHIL COUNT DECREASED 178
135 PARANOIA 178
136 DRUG LEVEL INCREASED 177
137 HYPOKALAEMIA 177
138 COUGH 175
139 MEDICATION ERROR 172
140 NEUTROPHIL COUNT INCREASED 172
141 VISION BLURRED 172
142 DRUG WITHDRAWAL SYNDROME 171
143 HAEMOGLOBIN DECREASED 171
144 SYNCOPE 171
145 MEMORY IMPAIRMENT 167
146 FEELING ABNORMAL 166
147 INTENTIONAL SELF-INJURY 166
148 ASPARTATE AMINOTRANSFERASE INCREASED 165
149 ATRIAL FIBRILLATION 164
150 HYPERTHERMIA 163
151 INTENTIONAL PRODUCT MISUSE 163
152 OBESITY 162
153 CARDIAC FAILURE 160
154 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 158
155 CHRONIC KIDNEY DISEASE 155
156 DISEASE PROGRESSION 155
157 PRODUCT USE ISSUE 154
158 DISINHIBITION 153
159 C-REACTIVE PROTEIN INCREASED 149
160 CONVULSION 149
161 INCORRECT DOSE ADMINISTERED 148
162 URINARY INCONTINENCE 148
163 INFECTION 147
164 WITHDRAWAL SYNDROME 147
165 DRUG INTOLERANCE 146
166 COVID-19 144
167 MATERNAL EXPOSURE DURING PREGNANCY 144
168 SEPTIC SHOCK 143
169 ARRHYTHMIA 142
170 DRUG RESISTANCE 142
171 NEUROPATHY PERIPHERAL 142
172 PRESCRIBED OVERDOSE 141
173 FOETAL EXPOSURE DURING PREGNANCY 140
174 BLOOD GLUCOSE INCREASED 138
175 HYPOGLYCAEMIA 138
176 RENAL FAILURE ACUTE 138
177 SLEEP DISORDER 137
178 HEART RATE INCREASED 134
179 PLEURAL EFFUSION 133
180 METABOLIC ACIDOSIS 132
181 AMNESIA 131
182 HALLUCINATION, VISUAL 131
183 MUSCLE SPASMS 129
184 MYALGIA 129
185 ALOPECIA 128
186 NEUROTOXICITY 127
187 RESPIRATORY DISTRESS 127
188 SOPOR 127
189 DEPRESSED MOOD 126
190 THERAPEUTIC PRODUCT EFFECT VARIABLE 124
191 HYPERGLYCAEMIA 123
192 EXPOSURE DURING PREGNANCY 122
193 SINUS TACHYCARDIA 121
194 EPILEPSY 120
195 LYMPHOCYTE COUNT DECREASED 118
196 ARTHRALGIA 117
197 TACHYPNOEA 117
198 TOXIC EPIDERMAL NECROLYSIS 117
199 BLOOD PRESSURE INCREASED 116
200 CEREBROVASCULAR ACCIDENT 116
201 PRIAPISM 116
202 BRADYKINESIA 115
203 DEEP VEIN THROMBOSIS 115
204 PSYCHOTIC SYMPTOM 115
205 BACK PAIN 113
206 CELLULITIS 113
207 DROOLING 113
208 HYPERSENSITIVITY 113
209 OCULOGYRIC CRISIS 111
210 ABDOMINAL PAIN UPPER 109
211 BLOOD PRESSURE DECREASED 109
212 MYOCARDIAL INFARCTION 109
213 CHILLS 108
214 FEBRILE NEUTROPENIA 108
215 GENERALISED TONIC-CLONIC SEIZURE 108
216 MOVEMENT DISORDER 108
217 OXYGEN SATURATION DECREASED 108
218 AGRANULOCYTOSIS 107
219 DYSLIPIDAEMIA 107
220 TYPE 2 DIABETES MELLITUS 107
221 BALANCE DISORDER 106
222 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 106
223 ANTICHOLINERGIC SYNDROME 105
224 COGWHEEL RIGIDITY 104
225 DRUG TOXICITY 103
226 DYSPEPSIA 102
227 EATING DISORDER 102
228 ILEUS PARALYTIC 101
229 MALIGNANT NEOPLASM PROGRESSION 101
230 PAIN IN EXTREMITY 101
231 RESPIRATORY DEPRESSION 101
232 EMOTIONAL DISTRESS 100
233 LOWER RESPIRATORY TRACT INFECTION 100
234 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 99
235 PANCYTOPENIA 99
236 SUDDEN DEATH 99
237 VISUAL IMPAIRMENT 99
238 HYPERREFLEXIA 98
239 PULMONARY OEDEMA 98
240 DEMENTIA 97
241 DRY MOUTH 96
242 HYPERTONIA 96
243 ABDOMINAL DISTENSION 95
244 ADVERSE DRUG REACTION 95
245 NERVOUS SYSTEM DISORDER 95
246 AFFECTIVE DISORDER 94
247 PERIPHERAL SWELLING 94
248 RESPIRATORY ARREST 94
249 ERYTHEMA 93
250 THERAPEUTIC RESPONSE DECREASED 93
251 ANTIPSYCHOTIC DRUG LEVEL INCREASED 92
252 GRANULOCYTOPENIA 92
253 MUCOSAL INFLAMMATION 92
254 MUSCLE TWITCHING 92
255 BLISTER 91
256 MULTIPLE ORGAN DYSFUNCTION SYNDROME 91
257 PERSECUTORY DELUSION 91
258 STEVENS-JOHNSON SYNDROME 91
259 MUSCULAR WEAKNESS 90
260 ORTHOSTATIC HYPOTENSION 90
261 VENTRICULAR FIBRILLATION 90
262 VENTRICULAR TACHYCARDIA 90
263 EMBOLISM VENOUS 89
264 APATHY 88
265 GASTROINTESTINAL HAEMORRHAGE 88
266 ACUTE RESPIRATORY FAILURE 87
267 ADVERSE EVENT 87
268 STUPOR 87
269 SWOLLEN TONGUE 87
270 LIVER FUNCTION TEST ABNORMAL 86
271 THINKING ABNORMAL 86
272 SCHIZOAFFECTIVE DISORDER 85
273 SINUS BRADYCARDIA 85
274 EMOTIONAL POVERTY 83
275 GASTROINTESTINAL DISORDER 83
276 HYPOPHAGIA 83
277 AUTONOMIC NERVOUS SYSTEM IMBALANCE 82
278 LEUKAEMIA 82
279 POISONING 82
280 BRAIN INJURY 81
281 PALPITATIONS 81
282 SOCIAL AVOIDANT BEHAVIOUR 81
283 ANGIOEDEMA 80
284 BLOOD ALKALINE PHOSPHATASE INCREASED 80
285 BODY TEMPERATURE INCREASED 80
286 PERICARDIAL EFFUSION 80
287 PSYCHOMOTOR RETARDATION 80
288 SEDATION COMPLICATION 80
289 ACCIDENTAL OVERDOSE 79
290 ASPIRATION 79
291 CARDIAC DISORDER 79
292 DELUSION OF GRANDEUR 79
293 BLOOD TRIGLYCERIDES INCREASED 78
294 CYANOSIS 78
295 REBOUND EFFECT 78
296 BLOOD PROLACTIN INCREASED 77
297 TORTICOLLIS 77
298 HYPERKALAEMIA 76
299 HYPOTHYROIDISM 76
300 HEPATIC ENZYME INCREASED 75
301 PARKINSON^S DISEASE 75
302 THERAPY PARTIAL RESPONDER 75
303 BLOOD CHOLESTEROL INCREASED 74
304 HYPOAESTHESIA 74
305 ABDOMINAL DISCOMFORT 72
306 BRAIN OEDEMA 72
307 GASTROOESOPHAGEAL REFLUX DISEASE 72
308 REFUSAL OF TREATMENT BY PATIENT 72
309 SHOCK 72
310 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 71
311 POLYDIPSIA 71
312 SEXUAL DYSFUNCTION 71
313 CARDIOMYOPATHY 70
314 BLOOD UREA INCREASED 69
315 CIRCULATORY COLLAPSE 69
316 EOSINOPHILIA 69
317 RASH MACULO-PAPULAR 68
318 DRUG DEPENDENCE 67
319 INTESTINAL OBSTRUCTION 67
320 PRODUCT DOSE OMISSION ISSUE 67
321 CHOKING 66
322 HYPERSOMNIA 66
323 MUTISM 66
324 DIABETIC KETOACIDOSIS 65
325 TRANSAMINASES INCREASED 65
326 HEPATIC FUNCTION ABNORMAL 64
327 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64
328 MIOSIS 64
329 MYDRIASIS 64
330 ERECTILE DYSFUNCTION 63
331 HAEMATOCRIT DECREASED 63
332 MOBILITY DECREASED 63
333 RESPIRATORY DISORDER 63
334 DISEASE RECURRENCE 62
335 EMOTIONAL DISORDER 62
336 METABOLIC DISORDER 62
337 OROPHARYNGEAL PAIN 62
338 PANCREATITIS 62
339 ACUTE RESPIRATORY DISTRESS SYNDROME 61
340 APHASIA 61
341 BIPOLAR DISORDER 61
342 HAEMATEMESIS 61
343 INTENTIONAL PRODUCT USE ISSUE 61
344 PARAESTHESIA 61
345 PLATELET COUNT INCREASED 61
346 PRODUCTIVE COUGH 61
347 FEAR 60
348 HALLUCINATIONS, MIXED 60
349 HYPERAMMONAEMIA 60
350 MALIGNANT CATATONIA 60
351 OEDEMA 60
352 GYNAECOMASTIA 59
353 ANGER 58
354 CONTUSION 58
355 FAECALOMA 58
356 HYPERNATRAEMIA 58
357 INTERNATIONAL NORMALISED RATIO INCREASED 58
358 ATAXIA 57
359 BEHAVIOUR DISORDER 57
360 BLOOD SODIUM DECREASED 57
361 STRESS 57
362 ACUTE MYOCARDIAL INFARCTION 56
363 GALACTORRHOEA 56
364 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56
365 LYMPHADENOPATHY 56
366 COLITIS ISCHAEMIC 55
367 END STAGE RENAL DISEASE 55
368 RESTLESS LEGS SYNDROME 55
369 SARS-COV-2 TEST POSITIVE 55
370 CONTRAINDICATED PRODUCT ADMINISTERED 54
371 EYE MOVEMENT DISORDER 54
372 LIVER DISORDER 54
373 NEOPLASM PROGRESSION 54
374 RED BLOOD CELL COUNT DECREASED 54
375 RHINORRHOEA 54
376 TROPONIN INCREASED 54
377 TUBULOINTERSTITIAL NEPHRITIS 54
378 ASCITES 53
379 COORDINATION ABNORMAL 53
380 GASTRITIS 53
381 ILEUS 53
382 INCONTINENCE 53
383 NASOPHARYNGITIS 53
384 NERVOUSNESS 53
385 RENAL DISORDER 53
386 STAPHYLOCOCCAL INFECTION 53
387 VENTRICULAR EXTRASYSTOLES 53
388 INJURY 52
389 LYMPHOCYTE COUNT ABNORMAL 52
390 MIGRAINE 52
391 PALLOR 52
392 RECTAL HAEMORRHAGE 52
393 AMENORRHOEA 51
394 BLOOD POTASSIUM DECREASED 51
395 DYSURIA 51
396 ELECTROLYTE IMBALANCE 51
397 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51
398 LACTIC ACIDOSIS 51
399 METABOLIC SYNDROME 51
400 NIGHTMARE 51
401 PANCREATITIS ACUTE 51
402 PREMATURE BABY 51
403 PULMONARY CONGESTION 51
404 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 51
405 SWELLING FACE 51
406 ANAPHYLACTIC REACTION 50
407 BLOOD LACTATE DEHYDROGENASE INCREASED 50
408 HAEMODYNAMIC INSTABILITY 50
409 RHINALGIA 50
410 TIC 50
411 TRISMUS 50
412 CLONUS 49
413 HEPATOCELLULAR INJURY 49
414 OROMANDIBULAR DYSTONIA 49
415 ANHEDONIA 48
416 CHEST DISCOMFORT 48
417 DRUG EFFECT DECREASED 48
418 HEPATITIS 48
419 NO ADVERSE EVENT 48
420 BLOOD ALBUMIN DECREASED 47
421 COMA SCALE ABNORMAL 47
422 DRUG-INDUCED LIVER INJURY 47
423 HEPATOTOXICITY 47
424 HYPERVENTILATION 47
425 LUNG DISORDER 47
426 MYOCARDIAL ISCHAEMIA 47
427 PERICARDITIS 47
428 BLOOD PHOSPHORUS DECREASED 46
429 DRUG DOSE OMISSION 46
430 ENCEPHALITIS AUTOIMMUNE 46
431 GASTROENTERITIS 46
432 HAEMATURIA 46
433 HEAD INJURY 46
434 HYPERAMMONAEMIC ENCEPHALOPATHY 46
435 HYPOKINESIA 46
436 INFLAMMATION 46
437 PSYCHIATRIC SYMPTOM 46
438 ACUTE PSYCHOSIS 45
439 EPISTAXIS 45
440 HYPOCALCAEMIA 45
441 INCORRECT ROUTE OF DRUG ADMINISTRATION 45
442 SKIN EXFOLIATION 45
443 CARDIAC FAILURE CONGESTIVE 44
444 CHOLELITHIASIS 44
445 CONJUNCTIVITIS 44
446 GLOMERULAR FILTRATION RATE DECREASED 44
447 GRAND MAL CONVULSION 44
448 HEPATIC FAILURE 44
449 HYPOMAGNESAEMIA 44
450 INTERSTITIAL LUNG DISEASE 44
451 TENSION 44
452 BLOOD BILIRUBIN INCREASED 43
453 BRADYPHRENIA 43
454 COLITIS 43
455 ELECTROENCEPHALOGRAM ABNORMAL 43
456 HAEMORRHAGE 43
457 RESPIRATORY TRACT INFECTION 43
458 TONGUE DISORDER 43
459 UPPER RESPIRATORY TRACT INFECTION 43
460 ACUTE HEPATIC FAILURE 42
461 COVID-19 PNEUMONIA 42
462 DISSEMINATED INTRAVASCULAR COAGULATION 42
463 DRUG EXPOSURE DURING PREGNANCY 42
464 GESTATIONAL DIABETES 42
465 IMPAIRED GASTRIC EMPTYING 42
466 JOINT SWELLING 42
467 NEPHROGENIC DIABETES INSIPIDUS 42
468 THERAPY CESSATION 42
469 WHEEZING 42
470 ANGINA PECTORIS 41
471 BLINDNESS 41
472 CHOLESTASIS 41
473 HYPERCHOLESTEROLAEMIA 41
474 HYPOTONIA 41
475 RESPIRATORY ALKALOSIS 41
476 SPASMODIC DYSPHONIA 41
477 THROMBOSIS 41
478 UNEVALUABLE EVENT 41
479 VENTRICULAR ARRHYTHMIA 41
480 CARDIOGENIC SHOCK 40
481 CEREBRAL ATROPHY 40
482 COMMUNICATION DISORDER 40
483 DRUG DISPENSING ERROR 40
484 DYSSTASIA 40
485 EOSINOPHIL COUNT DECREASED 40
486 EOSINOPHIL COUNT INCREASED 40
487 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 40
488 MAJOR DEPRESSION 40
489 MOOD ALTERED 40
490 NECK PAIN 40
491 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40
492 SUDDEN CARDIAC DEATH 40
493 ASPHYXIA 39
494 BRUXISM 39
495 FEELING HOT 39
496 HEMIPARESIS 39
497 HEPATIC STEATOSIS 39
498 IMPULSIVE BEHAVIOUR 39
499 PARADOXICAL DRUG REACTION 39
500 POLLAKIURIA 39
501 ABASIA 38
502 ABNORMAL WEIGHT GAIN 38
503 CHOREA 38
504 FEMORAL NECK FRACTURE 38
505 INJECTION SITE PAIN 38
506 KLEBSIELLA INFECTION 38
507 MULTI-ORGAN FAILURE 38
508 PANIC ATTACK 38
509 PRODUCT ADMINISTRATION ERROR 38
510 RETCHING 38
511 TINNITUS 38
512 URTICARIA 38
513 DYSPHONIA 37
514 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37
515 INFLUENZA 37
516 NEURALGIA 37
517 OSTEOARTHRITIS 37
518 POSTURE ABNORMAL 37
519 RASH MACULAR 37
520 RENAL TUBULAR NECROSIS 37
521 ROAD TRAFFIC ACCIDENT 37
522 SCREAMING 37
523 SWELLING 37
524 APNOEA 36
525 BLOOD PROLACTIN ABNORMAL 36
526 CATARACT 36
527 DISCOMFORT 36
528 DRUG EFFECT INCOMPLETE 36
529 OCULAR HYPERAEMIA 36
530 VERTIGO 36
531 ACNE 35
532 DRUG LEVEL DECREASED 35
533 HIP FRACTURE 35
534 INFLUENZA LIKE ILLNESS 35
535 JAUNDICE 35
536 LEFT VENTRICULAR DYSFUNCTION 35
537 POLYURIA 35
538 PRODUCT QUALITY ISSUE 35
539 RASH ERYTHEMATOUS 35
540 RESTING TREMOR 35
541 SKIN LESION 35
542 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35
543 ATRIAL FLUTTER 34
544 DEPRESSIVE SYMPTOM 34
545 FLUSHING 34
546 FRACTURE 34
547 INCOHERENT 34
548 LIVER INJURY 34
549 MOTOR DYSFUNCTION 34
550 MUSCLE TIGHTNESS 34
551 NO THERAPEUTIC RESPONSE 34
552 NYSTAGMUS 34
553 SELF INJURIOUS BEHAVIOUR 34
554 STAPHYLOCOCCAL SEPSIS 34
555 STOMATITIS 34
556 THERAPEUTIC AGENT TOXICITY 34
557 TRANSIENT ISCHAEMIC ATTACK 34
558 DRUG LEVEL BELOW THERAPEUTIC 33
559 ECONOMIC PROBLEM 33
560 FLATULENCE 33
561 HOT FLUSH 33
562 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33
563 NEGATIVISM 33
564 PLASMA CELL MYELOMA 33
565 PSYCHIATRIC DECOMPENSATION 33
566 SELF-INJURIOUS IDEATION 33
567 AFFECT LABILITY 32
568 APRAXIA 32
569 BUNDLE BRANCH BLOCK RIGHT 32
570 CARDIAC FAILURE ACUTE 32
571 DRUG LEVEL ABOVE THERAPEUTIC 32
572 DYSPNOEA EXERTIONAL 32
573 ELECTROCARDIOGRAM ABNORMAL 32
574 FEELING GUILTY 32
575 GAZE PALSY 32
576 HYPERLIPIDAEMIA 32
577 MOOD SWINGS 32
578 RESPIRATORY ACIDOSIS 32
579 RESPIRATORY RATE INCREASED 32
580 SLEEP APNOEA SYNDROME 32
581 ACCIDENTAL EXPOSURE 31
582 ARTHRITIS 31
583 BLOOD POTASSIUM INCREASED 31
584 BLUNTED AFFECT 31
585 BRAIN DEATH 31
586 BRONCHITIS 31
587 DIABETES MELLITUS INADEQUATE CONTROL 31
588 EJECTION FRACTION DECREASED 31
589 HAEMOLYTIC ANAEMIA 31
590 HEPATIC CYTOLYSIS 31
591 LUNG INFILTRATION 31
592 METASTASES TO CENTRAL NERVOUS SYSTEM 31
593 UPPER GASTROINTESTINAL HAEMORRHAGE 31
594 ASTHMA 30
595 CRYING 30
596 CYTOKINE RELEASE SYNDROME 30
597 DRUG ERUPTION 30
598 DYSPHORIA 30
599 HYPERTHYROIDISM 30
600 HYPERTRIGLYCERIDAEMIA 30
601 MOUTH ULCERATION 30
602 ORAL CANDIDIASIS 30
603 PERITONITIS 30
604 PNEUMONITIS 30
605 POOR QUALITY SLEEP 30
606 PROTRUSION TONGUE 30
607 PSEUDOMONAS INFECTION 30
608 SUBSTANCE ABUSE 30
609 SUSPECTED SUICIDE 30
610 AKINESIA 29
611 ATRIOVENTRICULAR BLOCK COMPLETE 29
612 CACHEXIA 29
613 CEREBRAL HAEMORRHAGE 29
614 CLOSTRIDIUM DIFFICILE COLITIS 29
615 CYSTITIS 29
616 FEMUR FRACTURE 29
617 GAIT INABILITY 29
618 HAEMATOCHEZIA 29
619 HEART RATE DECREASED 29
620 HEART RATE IRREGULAR 29
621 HEPATIC ENCEPHALOPATHY 29
622 HYPERCALCAEMIA 29
623 LYMPHOPENIA 29
624 NEPHROGENIC ANAEMIA 29
625 NEUTROPHILIA 29
626 POTENTIATING DRUG INTERACTION 29
627 RENAL INJURY 29
628 SELF-MEDICATION 29
629 VIRAL INFECTION 29
630 ATELECTASIS 28
631 BLOOD PRESSURE SYSTOLIC INCREASED 28
632 CARDIOTOXICITY 28
633 ENCEPHALITIS 28
634 HOSTILITY 28
635 HYPERTRANSAMINASAEMIA 28
636 IMMOBILE 28
637 LEFT VENTRICULAR HYPERTROPHY 28
638 MALNUTRITION 28
639 NEOPLASM MALIGNANT 28
640 OLIGURIA 28
641 PARKINSONIAN GAIT 28
642 PERIORBITAL OEDEMA 28
643 PHOTOPSIA 28
644 PULSELESS ELECTRICAL ACTIVITY 28
645 STATUS EPILEPTICUS 28
646 THERAPEUTIC PRODUCT EFFECT DECREASED 28
647 TYPE 1 DIABETES MELLITUS 28
648 VISCERAL CONGESTION 28
649 ABORTION SPONTANEOUS 27
650 ACUTE PULMONARY OEDEMA 27
651 CARDIOVASCULAR DISORDER 27
652 DRUG WITHDRAWAL SYNDROME NEONATAL 27
653 HYPERCAPNIA 27
654 HYPOMANIA 27
655 HYPORESPONSIVE TO STIMULI 27
656 JOINT STIFFNESS 27
657 MUSCLE CONTRACTIONS INVOLUNTARY 27
658 PAROXYSMAL PERCEPTUAL ALTERATION 27
659 PNEUMOTHORAX 27
660 PRODUCT PACKAGING ISSUE 27
661 PSORIASIS 27
662 STARING 27
663 SURGERY 27
664 UROSEPSIS 27
665 ABDOMINAL PAIN LOWER 26
666 BLOOD TEST ABNORMAL 26
667 BONE MARROW FAILURE 26
668 CANDIDA INFECTION 26
669 DECUBITUS ULCER 26
670 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 26
671 EYELID OEDEMA 26
672 FLUID RETENTION 26
673 HYPERLACTACIDAEMIA 26
674 ILL-DEFINED DISORDER 26
675 ISCHAEMIA 26
676 JOINT DISLOCATION 26
677 MEGACOLON 26
678 NIKOLSKY^S SIGN 26
679 OSTEOPOROSIS 26
680 RASH GENERALISED 26
681 WATER INTOXICATION 26
682 ANOREXIA 25
683 APHONIA 25
684 BONE PAIN 25
685 BREAST CANCER 25
686 BUNDLE BRANCH BLOCK LEFT 25
687 ECHOLALIA 25
688 HAEMODIALYSIS 25
689 HOMICIDAL IDEATION 25
690 HYPOALBUMINAEMIA 25
691 LOGORRHOEA 25
692 LYMPHOCYTE COUNT INCREASED 25
693 MITRAL VALVE INCOMPETENCE 25
694 MULTIPLE DRUG OVERDOSE 25
695 PARALYSIS 25
696 PETIT MAL EPILEPSY 25
697 THERAPEUTIC RESPONSE UNEXPECTED 25
698 TOXIC ENCEPHALOPATHY 25
699 UNDERDOSE 25
700 ACCIDENTAL EXPOSURE TO PRODUCT 24
701 ACTIVITIES OF DAILY LIVING IMPAIRED 24
702 BODY TEMPERATURE DECREASED 24
703 CARDIAC DYSFUNCTION 24
704 CEREBRAL INFARCTION 24
705 COAGULOPATHY 24
706 DRUG ADMINISTRATION ERROR 24
707 DYSPHEMIA 24
708 EYE DISORDER 24
709 FACE OEDEMA 24
710 GENERAL PHYSICAL CONDITION ABNORMAL 24
711 INTENTIONAL DOSE OMISSION 24
712 LIVER FUNCTION TEST INCREASED 24
713 LONG QT SYNDROME 24
714 METASTASES TO LUNG 24
715 ODYNOPHAGIA 24
716 PURPURA 24
717 RENAL CYST 24
718 RENAL NEOPLASM 24
719 SUBDURAL HAEMATOMA 24
720 TOXIC SKIN ERUPTION 24
721 AMMONIA INCREASED 23
722 ATRIOVENTRICULAR BLOCK 23
723 AZOTAEMIA 23
724 BEDRIDDEN 23
725 BLOOD SODIUM INCREASED 23
726 CORONARY ARTERY DISEASE 23
727 DEMENTIA WITH LEWY BODIES 23
728 DERMATITIS BULLOUS 23
729 DIABETIC COMA 23
730 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23
731 HAEMORRHOIDS 23
732 HEAD TITUBATION 23
733 HYDRONEPHROSIS 23
734 HYPERKINESIA 23
735 HYPERPHAGIA 23
736 LIP SWELLING 23
737 NEPHROPATHY TOXIC 23
738 PRODUCT SUBSTITUTION ISSUE 23
739 RESUSCITATION 23
740 SKIN INFECTION 23
741 THIRST 23
742 TONIC CLONIC MOVEMENTS 23
743 ADENOMA BENIGN 22
744 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 22
745 ANURIA 22
746 BACTERIAL INFECTION 22
747 BORDERLINE PERSONALITY DISORDER 22
748 CAESAREAN SECTION 22
749 CARDIOMEGALY 22
750 DISSOCIATION 22
751 ENURESIS 22
752 FAILURE TO THRIVE 22
753 GENERALISED OEDEMA 22
754 GLYCOSYLATED HAEMOGLOBIN INCREASED 22
755 HAEMOPTYSIS 22
756 HEPATITIS ACUTE 22
757 HYPERTHERMIA MALIGNANT 22
758 HYPOVENTILATION 22
759 MULTIPLE DRUG THERAPY 22
760 MUSCULOSKELETAL PAIN 22
761 OPISTHOTONUS 22
762 ORAL DISORDER 22
763 PANCREATITIS NECROTISING 22
764 PAROTITIS 22
765 PERSONALITY CHANGE 22
766 POST-TRAUMATIC STRESS DISORDER 22
767 PRODUCT PRESCRIBING ISSUE 22
768 SEXUALLY INAPPROPRIATE BEHAVIOUR 22
769 TONGUE BITING 22
770 TOOTH LOSS 22
771 URINE OUTPUT DECREASED 22
772 VENOUS THROMBOSIS LIMB 22
773 VULVOVAGINAL CANDIDIASIS 22
774 WAXY FLEXIBILITY 22
775 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22
776 BLOOD BICARBONATE DECREASED 21
777 BLOOD MAGNESIUM DECREASED 21
778 BRONCHOPNEUMONIA 21
779 CENTRAL NERVOUS SYSTEM LESION 21
780 DEVICE RELATED INFECTION 21
781 ILLNESS 21
782 JAW DISORDER 21
783 LACRIMATION INCREASED 21
784 MELAENA 21
785 MONOCYTE COUNT INCREASED 21
786 NEUTROPENIC SEPSIS 21
787 NOCTURIA 21
788 POSTURING 21
789 PULSE ABSENT 21
790 REFUSAL OF EXAMINATION 21
791 SKIN ULCER 21
792 SUPRAVENTRICULAR TACHYCARDIA 21
793 THERAPY INTERRUPTED 21
794 VOLVULUS 21
795 WRONG PRODUCT ADMINISTERED 21
796 ANAL INCONTINENCE 20
797 APALLIC SYNDROME 20
798 ARTHROPATHY 20
799 BLOOD CALCIUM DECREASED 20
800 BLOOD GLUCOSE ABNORMAL 20
801 BLOOD LACTIC ACID INCREASED 20
802 BLOOD PRESSURE FLUCTUATION 20
803 CARDIOPULMONARY FAILURE 20
804 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20
805 DRY SKIN 20
806 ECZEMA 20
807 ELECTROCARDIOGRAM T WAVE ABNORMAL 20
808 ENDOTRACHEAL INTUBATION 20
809 FOOD POISONING 20
810 GRANDIOSITY 20
811 HYPERTENSIVE CRISIS 20
812 HYPOPARATHYROIDISM 20
813 INTENTIONAL DRUG MISUSE 20
814 INTESTINAL ISCHAEMIA 20
815 MYOPATHY 20
816 NORMAL NEWBORN 20
817 PHYSICAL ASSAULT 20
818 PRODUCT DOSE OMISSION 20
819 PULMONARY HYPERTENSION 20
820 RASH PRURITIC 20
821 REDUCED FACIAL EXPRESSION 20
822 SCHIZOPHRENIA, PARANOID TYPE 20
823 SMALL INTESTINAL OBSTRUCTION 20
824 SPLENOMEGALY 20
825 STEREOTYPY 20
826 THERAPY CHANGE 20
827 TROPONIN I INCREASED 20
828 VERBAL ABUSE 20
829 WOUND 20
830 ACUTE CORONARY SYNDROME 19
831 ANAPHYLACTIC SHOCK 19
832 BLOOD GLUCOSE DECREASED 19
833 CHROMATURIA 19
834 CLOSTRIDIUM DIFFICILE INFECTION 19
835 COLD SWEAT 19
836 COLONIC PSEUDO-OBSTRUCTION 19
837 DERMATITIS EXFOLIATIVE 19
838 DIALYSIS 19
839 DIPLOPIA 19
840 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19
841 ENCEPHALITIS TOXIC 19
842 FULL BLOOD COUNT DECREASED 19
843 GLUCOSE TOLERANCE IMPAIRED 19
844 HEAD DISCOMFORT 19
845 HOSPICE CARE 19
846 HYPERBILIRUBINAEMIA 19
847 HYPERSEXUALITY 19
848 HYPOAESTHESIA ORAL 19
849 HYPOREFLEXIA 19
850 ISCHAEMIC STROKE 19
851 LOW BIRTH WEIGHT BABY 19
852 LUNG NEOPLASM MALIGNANT 19
853 MULTIPLE FRACTURES 19
854 NUCHAL RIGIDITY 19
855 PITUITARY TUMOUR BENIGN 19
856 SNORING 19
857 SPINAL COMPRESSION FRACTURE 19
858 SPUTUM DISCOLOURED 19
859 SUICIDAL BEHAVIOUR 19
860 TACHYPHRENIA 19
861 URETERIC OBSTRUCTION 19
862 VICTIM OF CRIME 19
863 ABSCESS 18
864 ANOSOGNOSIA 18
865 BLOOD IRON DECREASED 18
866 CEREBRAL DISORDER 18
867 CEREBRAL ISCHAEMIA 18
868 CHOLECYSTITIS 18
869 COMPULSIVE SEXUAL BEHAVIOUR 18
870 CONSCIOUSNESS FLUCTUATING 18
871 FACIAL PARALYSIS 18
872 GRIMACING 18
873 HEPATOMEGALY 18
874 INAPPROPRIATE AFFECT 18
875 INTESTINAL DILATATION 18
876 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18
877 LABILE BLOOD PRESSURE 18
878 METASTASES TO BONE 18
879 MUSCULOSKELETAL CHEST PAIN 18
880 MYOCARDIAL REPERFUSION INJURY 18
881 ORTHOPNOEA 18
882 OSCILLOPSIA 18
883 PARAPARESIS 18
884 PELVIC FRACTURE 18
885 PRESCRIBED UNDERDOSE 18
886 PRODUCT ADMINISTRATION INTERRUPTED 18
887 PROTEIN TOTAL DECREASED 18
888 PSYCHOMOTOR SKILLS IMPAIRED 18
889 SLOW SPEECH 18
890 SYMPTOM MASKED 18
891 ACIDOSIS 17
892 ACUTE MYELOID LEUKAEMIA 17
893 ANGIOPATHY 17
894 BACTERAEMIA 17
895 BLOOD CHLORIDE DECREASED 17
896 BLOOD CHOLESTEROL ABNORMAL 17
897 BLOOD DISORDER 17
898 BREAST ENLARGEMENT 17
899 BURNING SENSATION 17
900 CHOLINERGIC SYNDROME 17
901 CIRCADIAN RHYTHM SLEEP DISORDER 17
902 DRUG SCREEN POSITIVE 17
903 DRUG-GENETIC INTERACTION 17
904 EMPHYSEMA 17
905 ERYSIPELAS 17
906 EYE SWELLING 17
907 FAECES DISCOLOURED 17
908 FIBRIN D DIMER INCREASED 17
909 GASTRIC ULCER 17
910 GASTROINTESTINAL NECROSIS 17
911 HUNGER 17
912 HYPERPYREXIA 17
913 INFLAMMATORY MARKER INCREASED 17
914 METASTASES TO LIVER 17
915 NEPHROLITHIASIS 17
916 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17
917 POST PROCEDURAL COMPLICATION 17
918 PRODUCT PRESCRIBING ERROR 17
919 SINUSITIS 17
920 SKIN DISORDER 17
921 SLUGGISHNESS 17
922 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17
923 UMBILICAL HERNIA 17
924 VARICOSE VEIN 17
925 WRONG PATIENT RECEIVED PRODUCT 17
926 ALCOHOL ABUSE 16
927 ANTICONVULSANT DRUG LEVEL INCREASED 16
928 ARTERIOSCLEROSIS 16
929 BASAL CELL CARCINOMA 16
930 BIPOLAR I DISORDER 16
931 BONE DISORDER 16
932 BRONCHOSPASM 16
933 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16
934 DECREASED ACTIVITY 16
935 DENTAL CARIES 16
936 DIABETIC NEUROPATHY 16
937 DIET REFUSAL 16
938 DISTRACTIBILITY 16
939 DRUG CLEARANCE DECREASED 16
940 DRUG MONITORING PROCEDURE NOT PERFORMED 16
941 DYSGEUSIA 16
942 ELECTROCARDIOGRAM PR PROLONGATION 16
943 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16
944 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16
945 ELECTROCARDIOGRAM T WAVE INVERSION 16
946 GAMBLING DISORDER 16
947 GASTRIC INFECTION 16
948 HEPATIC CIRRHOSIS 16
949 HYPOTONIA NEONATAL 16
950 ILLUSION 16
951 IMPAIRED SELF-CARE 16
952 INITIAL INSOMNIA 16
953 KIDNEY INFECTION 16
954 LIP EROSION 16
955 LIVE BIRTH 16
956 LOCAL SWELLING 16
957 MASKED FACIES 16
958 MATERNAL EXPOSURE BEFORE PREGNANCY 16
959 MUCOSAL DRYNESS 16
960 MULTIPLE MYELOMA 16
961 MUSCLE CONTRACTURE 16
962 NEGLECT OF PERSONAL APPEARANCE 16
963 OBSESSIVE THOUGHTS 16
964 PENIS DISORDER 16
965 PERSONALITY DISORDER 16
966 PETECHIAE 16
967 POISONING DELIBERATE 16
968 POOR FEEDING INFANT 16
969 PRESSURE OF SPEECH 16
970 PYELONEPHRITIS 16
971 REBOUND ACID HYPERSECRETION 16
972 RENAL CELL CARCINOMA 16
973 RENAL FAILURE CHRONIC 16
974 RIB FRACTURE 16
975 SKIN DISCOLOURATION 16
976 SUBARACHNOID HAEMORRHAGE 16
977 THROMBOPHLEBITIS 16
978 VENTRICULAR HYPERTROPHY 16
979 ABNORMAL DREAMS 15
980 ACCIDENT 15
981 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 15
982 BLOOD URINE PRESENT 15
983 BREATHING-RELATED SLEEP DISORDER 15
984 COMPLICATION ASSOCIATED WITH DEVICE 15
985 DISABILITY 15
986 DRY EYE 15
987 DUODENITIS 15
988 DYSCHEZIA 15
989 EMBOLISM 15
990 EXTRASYSTOLES 15
991 FEELING COLD 15
992 FEELING JITTERY 15
993 FLAT AFFECT 15
994 FLUID INTAKE REDUCED 15
995 FOETAL ARRHYTHMIA 15
996 FOETAL GROWTH RESTRICTION 15
997 HAEMATOMA 15
998 HALLUCINATION, OLFACTORY 15
999 HEPATITIS C 15